Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Centrexion Therapeutics Corporation
CNTX | US
2.06
USD0.02
0.98%
CNTX | US
About Centrexion Therapeutics Corporation
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
21/10/2024
Close
2.06
Open
2.06
High
2.08
Low
2.03
Context Therapeutics Inc. a biopharmaceutical company develops products for the treatment of solid tumors in the United States. It develops CLDN6xCD3 bsAb an anti-CD3 x anti-Claudin 6 antigen bispecific monoclonal antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular Inc. for the development of an anti-claudin 6 bispecific monoclonal antibody for cancer therapy. Context Therapeutics Inc. was incorporated in 2015 and is headquartered in Philadelphia Pennsylvania.
View LessCNTX | US
Risk
81.7
Sharpe
0.65
Luna's Score
43/100
Recommendation
Sell
Luna says (CNTX | US)
What's Working
Value Stock (Price to Book < 3)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
90.1%1 month
81.7%3 months
71.1%6 months
83.1%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
1.49
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
1.60
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-20.01M
MarketCap
154.50M
MarketCap(USD)
154.50M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-29.68
Short ratio
3.89
Short perc.
1.64
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
0.44
Range1M
0.71
Range3M
1.10
Volumes: Market Activity
Rel. volume
0.16
Price X volume
101.51K
